English

Qlife Holding AB publishes Annual Report for 2024

Report this content

Qlife Holding AB's ("Qlife") Annual Report is available on Qlife's website:

https://qlifeholding.com/en/investors/financial-reports

The Annual Report can be downloaded from the website or ordered from Qlife, info@egoo.health.

For further information, please contact:

Thomas Warthoe, CEO Qlife Holding

Email: tw@egoo.health

Phone: +45-21 63 35 34

About Qlife

Qlife is a medical technology company that aims to revolutionise the market for clinical whole blood biomarker testing. By making it possible to perform tests at home instead of in the hospital, access to blood samples is facilitated, which can promote monitoring of important parameters and contribute to better treatment. The company's share (QLIFE) is traded on Nasdaq First North Growth Market with G&W Fondkommission as Certified Adviser (e-mail: ca@gwkapital.se).

Read more at Egoo.health, Qlifeholding.com or follow us on LinkedIn.

Subscribe